Thyrocare Tech.

THYROCARETECHNOLOGIES03 May 2024

Healthcare

₹

-14.60 (-2.27%)

Lowest Today

Highest Today

Prev. Close

Today’s Open

52 Week High

52 Week Low

BUY

SELL

To Invest in Thyrocare Tech.

Thyrocare Tech.

Healthcare

THYROCARETECHNOLOGIES03 May 2024

₹

-14.60 (-2.27%)

OverviewFundamentals

Corporate action

Peer comparison

Income Sheet

Balance sheet

Cash flow

Share holding

About Us

Corporate Action

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

All

Dividends

Bonus

Splits

Others

Ex-Date	Type	Description	Record Date
07-Apr-2023	D	In continuation to our letter dated April 1, 2023 and in compliance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that the Board of Directors of the Company, at their meeting held on today, April 7, 2023, inter allia, have declared an interim dividend at the rate of INR 18/- (Rupees Eighteen only per share), (180% of the face value of INR 10/- each) for the financial year 2022-23. The Board has fixed, Thursday April 20, 2023 as the record date for the purpose of determining the entitlement of shareholders for the interim dividend	20-Apr-2023
30-Apr-2022	D	Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 29, 2022, inter alia, has decided to declare an interim dividend at the rate of Rs. 15.00 (Rupees Fifteen Only) per share (150% of the face value of Rs. 10/- each) for the financial year 2021-22.	11-May-2022
10-May-2021	D	Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 08, 2021, inter alia, have decided to recommend to the Shareholders for their approval, declaration of dividend at the rate of Rs. 15.00 (Rupees Fifteen only) per share (150% of the face value of Rs. 10/- each). Considering the interim dividend of Rs. 10/- already paid, the total dividend payout for FY 2020-21 would be Rs. 25/- per share (250% of the face value of Rs.10/-).	17-Jun-2021
29-Oct-2020	D	Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on October 28, 2020, inter alia, have approved payment of interim dividend for the financial year 2020-21, at the rate of Rs. 10/- (Rupees Ten only) per share (100% of the face value of Rs. 10/- each).	12-Nov-2020
07-Nov-2019	D	This is to inform you that the Board of Directors of the Company, at their meeting held today, approved the unaudited Financial Results (Stand-alone and Consolidated) for the Quarter / Half year ended September 30, 2019. The Board of Directors have also approved payment of interim dividend for the financial year 2019-20, at the rate of Rs. 5.00 (Rupees Five only) per share (50% of the face value of Rs. 10/- each).	21-Nov-2019
19-May-2019	D	Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at their meeting held on May 18, 2019, inter alia, decided to recommend to the Shareholders for their approval, declaration of dividend at the rate of Rs. 20.00 (Rupees Twenty only) per share (200% of the face value of Rs. 10/- each).	14-Aug-2019
30-Apr-2018	D	Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on April 28, 2018, inter alia, have recommended the payment of final dividend of Rs. 5/- (Rupees five only) per equity share of the face value of Rs. 10 each.	02-Aug-2018
03-Feb-2018	D	Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on February 03, 2018, inter alia, has declared an Interim Dividend of Rs. 5/- Per Share for the Financial Year 2017-18. This is to inform you that the Board of Directors of the Company, at their meeting held today, declared an Interim Dividend of Rs. 5/- Per Share for the Financial Year 2017-18. The Board of Directors have also fixed Friday, 16th February 2018 as the record date for the purpose of determining the eligibility of shareholders for the interim dividend.	15-Feb-2018
09-May-2017	D	Our Board today approved the Audited Financial Results (Stand-alone and Consolidated) for the Financial Year ended March 31, 2017 and have also decided to recommend declaration of final dividend at the rate of Rs. 5.00 per share to the Shareholders for their approval. The Meeting concluded at 8.15 p.m. today, and approved granting of Stock Options to the eligible employees of the Company for the year 2016-17 Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 09, 2017, inter alia, have also decided to recommend declaration of final dividend at the rate of Rs. 5.00 (Rupees Five only) per share (50% of the face value of Rs. 10/- each) to the Shareholders for their approval. The Meeting concluded at 8.15 p.m. (As Per BSE Announcement Dated on 10.05.2017)	03-Aug-2017
29-Jan-2017	D	Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at their meeting held on January 28, 2017, inter alia, has decided to pay an interim dividend of Rs. 5/- (Rupees Five only) per share for the financial year 2016-17.	08-Feb-2017
11-Jun-2016	D	Thyrocare Technologies Ltd has informed BSE that the Board of Directors of the Company at its meeting held on June 11, 2016, inter alia, have recommended a payment of final dividend of Rs. 2.50 (Rupees Two and Paise Fifty only) per equity share of the face value of Rs. 10 each for the financial year ended March 31, 2016. The Company has declared two interim dividends. These two interim dividends constitutes a total payout of Rs. 7.50 per equity share (75% on the face value of Rs. 10/- each) for the financial year 2015-2016. The Total dividend for the year including the final dividend (subject to the approval of the shareholders at the ensuing Annual General Meeting) will be Rs. 10/- (Rupees Ten only) per equity share.	01-Sep-2016
23-May-2023	BC	Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015	10-May-2024
16-Apr-2024	BC	Resignation of Mr. Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer of the company w.e.f April 26, 2024	26-Apr-2024
24-Jan-2024	BC	Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 inter alia to consider and approve Board meeting intimation for Approv	01-Feb-2024
01-Feb-2024	BC	1. appointment of Mr. Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer of the Company w.e.f. February 01, 2024;	01-Feb-2024
22-Dec-2023	BC	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Tuesda	26-Dec-2023

Announcement Date07-Apr-2023

Ex Dividend Date20-Apr-2023

Dividend(%)180

Announcement Date30-Apr-2022

Ex Dividend Date11-May-2022

Dividend(%)150

Announcement Date10-May-2021

Ex Dividend Date17-Jun-2021

Dividend(%)150

Announcement Date29-Oct-2020

Ex Dividend Date12-Nov-2020

Dividend(%)100

Announcement Date07-Nov-2019

Ex Dividend Date21-Nov-2019

Dividend(%)50

Announcement Date19-May-2019

Ex Dividend Date14-Aug-2019

Dividend(%)200

Announcement Date30-Apr-2018

Ex Dividend Date02-Aug-2018

Dividend(%)50

Announcement Date03-Feb-2018

Ex Dividend Date15-Feb-2018

Dividend(%)50

Announcement Date09-May-2017

Ex Dividend Date03-Aug-2017

Dividend(%)50

Announcement Date29-Jan-2017

Ex Dividend Date08-Feb-2017

Dividend(%)50

Announcement Date11-Jun-2016

Ex Dividend Date01-Sep-2016

Dividend(%)25

No Rights has been declared by THYROCARETECHNOLOGIES

Book Closure

Record Date	Split Date	Purpose
10-May-2024	-	Intimation under Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
26-Apr-2024	-	Resignation of Mr. Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer of the company w.e.f April 26, 2024
01-Feb-2024	-	Thyrocare Technologies Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 01/02/2024 inter alia to consider and approve Board meeting intimation for Approv
01-Feb-2024	-	1. appointment of Mr. Ankit Brijpuriya as Deputy Company Secretary and Deputy Compliance Officer of the Company w.e.f. February 01, 2024;
26-Dec-2023	-	Trading Members of the Exchange are hereby informed that the further new securities issued by the under mentioned companies are listed and admitted for trading on the Exchange with effect from Tuesda

Peer Comparison

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Scrip Name	Price	Daily Change	M.Cap (Cr)	1 Year Returns %	P/E (TTM)	PB Ratio
Thyrocare Technologies Ltd ₹629.55(-14.60/-2.27%)	629.55	-14.60	3,410.95	44.04	54.92	7.19
Shalby Ltd ₹268.45(-3.60/-1.32%)	268.45	-3.60	2,938.41	88.79	29.50	2.89
Fortis Healthcare Ltd ₹451.65(+11.35/2.58%)	451.65	+11.35	33,240.81	68.89	436.24	3.70
Poly Medicure Ltd ₹1,670.25(+28.85/1.76%)	1,670.25	+28.85	15,752.75	66.81	65.94	11.88
Mohini Health & Hygiene Ltd ₹61.00(-0.45/-0.73%)	61.00	-0.45	112.06	13.90	16.39	1.25
GPT Healthcare Ltd ₹171.50(+1.30/0.76%)	171.50	+1.30	1,396.57	0.00	28.60	6.54

Income Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	122.89	136.29	123.61	124.82	117.17	125.23
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	122.89	136.29	123.61	124.82	117.17	125.23
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.09	1.82	0.46	2.07	1.27	1.16
Total Income	124.98	138.11	124.07	126.89	118.44	126.39
Total Expenditure	92.36	99.66	90.49	102.05	91.26	95.69
PBIDT	32.62	38.45	33.58	24.84	27.18	30.70
Interest	0.96	1.02	0.80	0.60	0.59	0.51
PBDT	31.66	37.43	32.78	24.24	26.59	30.19
Depreciation	10.90	9.30	8.51	9.42	9.01	8.07
Tax	5.40	8.83	8.76	8.21	6.41	8.67
Deferred Tax	0.47	-0.99	-1.22	-3.32	-1.46	-0.85
Reported Profit After Tax	14.89	20.29	16.73	9.93	12.63	14.30
Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	14.89	20.29	16.73	9.93	12.63	14.30

EPS (Unit Curr.)	2.81	3.83	3.18	1.88	2.38	2.70
EPS (Adj) (Unit Curr.)	2.81	3.83	3.18	1.88	2.38	2.70
Calculated EPS (Unit Curr.)	2.81	3.83	3.16	1.88	2.39	2.70
Calculated EPS (Adj) (Unit Curr.)	2.81	3.83	3.16	1.88	2.39	2.70
Calculated EPS (Ann.) (Unit Curr.)	11.25	15.33	12.64	7.50	9.54	10.81
Calculated EPS (Adj) (Ann.) (Unit Curr.)	11.25	15.33	12.64	7.50	9.54	10.81
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	52.95	52.93	52.93	52.93	52.93	52.93
Reserve & Surplus	0.00	0.00	0.00	0.00	0.00	0.00
Face Value	10.00	10.00	10.00	10.00	10.00	10.00

Public Shareholding (No. Of Shares)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (% in Equity)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	26.54	28.21	27.17	19.90	23.20	24.51
PBDTM(%)	25.76	27.46	26.52	19.42	22.69	24.11
PATM(%)	12.12	14.89	13.53	7.96	10.78	11.42

Column	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22	Sep 22
Gross Sales	134.74	148.00	134.89	135.88	128.03	134.97
Excise Duty	0.00	0.00	0.00	0.00	0.00	0.00
Net Sales	134.74	148.00	134.89	135.88	128.03	134.97
Other Operating Income	0.00	0.00	0.00	0.00	0.00	0.00
Other Income	2.86	2.53	1.10	4.02	2.59	1.72
Total Income	137.60	150.53	135.99	139.90	130.62	136.69
Total Expenditure	103.15	110.48	100.38	111.19	100.17	103.39
PBIDT	34.45	40.05	35.61	28.71	30.45	33.30
Interest	1.07	1.13	0.88	0.67	0.58	0.54
PBDT	33.38	38.92	34.73	28.04	29.87	32.76
Depreciation	13.47	10.65	9.83	10.80	10.15	9.15
Minority Interest Before NP	0.00	0.00	0.00	0.00	0.00	0.00
Tax	5.40	8.83	8.76	8.21	6.40	8.67
Deferred Tax	-0.23	-0.89	-1.11	-3.46	-1.38	-0.49
Reported Profit After Tax	14.74	20.33	17.25	12.49	14.70	15.43
Minority Interest After NP	-0.61	-0.01	-0.05	-0.11	-0.02	0.00
Net Profit after Minority Interest	15.35	20.34	17.30	12.60	14.72	15.43

Extra-ordinary Items	0.00	0.00	0.00	0.00	0.00	0.00
Adjusted Profit After Extra-ordinary item	15.35	20.34	17.30	12.60	14.72	15.43

EPS (Unit Curr.)	2.78	3.84	3.26	2.36	2.78	3.80
Book Value (Unit Curr.)	0.00	0.00	0.00	0.00	0.00	0.00
Dividend (%)	0.00	0.00	0.00	0.00	0.00	0.00
Equity	52.95	52.93	52.93	52.93	52.93	52.93

Public Shareholding (Number)	0.00	0.00	0.00	0.00	0.00	0.00
Public Shareholding (%)	0.00	0.00	0.00	0.00	0.00	0.00

Pledged/Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Pledged/Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

Non Encumbered - No. of Shares	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Promoters Holding	0.00	0.00	0.00	0.00	0.00	0.00
Non Encumbered - % in Total Equity	0.00	0.00	0.00	0.00	0.00	0.00

PBIDTM(%)	25.57	27.06	26.40	21.13	23.78	24.67
PBDTM(%)	24.77	26.30	25.75	20.64	23.33	24.27
PATM(%)	10.94	13.74	12.79	9.19	11.48	11.43

Balance Sheet

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Standalone

Consolidated

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	52.93	52.90	52.87	52.84	52.80	53.72
Reserves Total	449.19	467.80	392.59	325.39	402.98	400.16
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	18.92	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	521.04	520.70	445.46	378.23	455.78	453.88
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	21.17	21.43	9.63	9.20	0.00	0.00
Total Debt	21.17	21.43	9.63	9.20	0.00	0.00
Total Liabilities	542.21	542.13	455.09	387.43	455.78	453.88
APPLICATION OF FUNDS :
Gross Block	278.95	246.29	192.94	167.12	145.42	125.86
Less : Accumulated Depreciation	122.28	96.90	73.79	55.56	37.16	22.90
Less:Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	156.67	149.39	119.15	111.56	108.26	102.96
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	0.82	2.15	8.28	3.87	1.28	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	273.94	259.39	273.81	239.37	289.31	314.77
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	27.05	24.22	22.16	18.49	15.56	16.47
Sundry Debtors	83.31	92.78	44.29	15.19	11.06	9.21
Cash and Bank	16.39	12.00	7.67	7.30	9.05	9.28
Loans and Advances	7.43	12.97	4.91	3.64	1.70	2.99
Total Current Assets	134.18	141.97	79.03	44.62	37.37	37.95
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	52.48	46.79	53.34	45.35	22.88	12.21
Provisions	14.01	8.08	5.92	1.73	1.64	6.12
Total Current Liabilities	66.49	54.87	59.26	47.08	24.52	18.33
Net Current Assets	67.69	87.10	19.77	-2.46	12.85	19.62
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	22.05	16.23	16.37	12.63	3.35	2.75
Deferred Tax Liability	0.75	0.48	1.51	0.99	1.73	2.34
Net Deferred Tax	21.30	15.75	14.86	11.64	1.62	0.41
Total Assets	520.42	513.78	435.87	363.98	413.32	437.76
Contingent Liabilities	0.85	0.85	50.07	53.57	40.46	47.52

Column	Mar 23	Mar 22	Mar 21	Mar 20	Mar 19	Mar 18
SOURCES OF FUNDS :
Share Capital	52.93	52.90	52.87	52.84	52.79	53.72
Reserves Total	462.45	473.67	374.41	313.81	382.33	389.57
Equity Share Warrants	0.00	0.00	0.00	0.00	0.00	0.00
Equity Application Money	18.92	0.00	0.00	0.00	0.00	0.00
Total Shareholders Funds	534.30	526.57	427.28	366.65	435.12	443.29
Minority Interest	0.92	0.00	0.00	0.00	0.00	0.00
Secured Loans	0.00	0.00	0.00	0.00	0.00	0.00
Unsecured Loans	23.31	20.70	8.49	12.44	2.50	0.00
Total Debt	23.31	20.70	8.49	12.44	2.50	0.00
Policy Holders Fund	0.00	0.00	0.00	0.00	0.00	0.00
Other Liabilities	3.30	0.27	13.58	8.16	16.51	15.41
Total Liabilities	561.83	547.54	449.35	387.25	454.13	458.70
APPLICATION OF FUNDS :
Gross Block	460.82	422.87	365.93	359.08	355.40	336.04
Less: Accumulated Depreciation	166.93	137.92	112.87	89.99	61.10	37.29
Less: Impairment of Assets	0.00	0.00	0.00	0.00	0.00	0.00
Net Block	293.89	284.95	253.06	269.09	294.30	298.75
Lease Adjustment	0.00	0.00	0.00	0.00	0.00	0.00
Capital Work in Progress	1.61	2.95	8.28	4.93	1.47	0.00
Producing Properties	0.00	0.00	0.00	0.00	0.00	0.00
Investments	144.40	146.13	125.59	90.20	95.30	120.10
Current Assets, Loans & Advances	0.00	0.00	0.00	0.00	0.00	0.00
Inventories	27.67	24.53	23.36	20.62	18.08	17.05
Sundry Debtors	85.12	93.20	44.68	16.30	12.16	9.84
Cash and Bank	28.47	13.91	15.73	11.07	9.60	11.86
Loans and Advances	9.38	13.17	52.18	34.97	21.54	3.55
Total Current Assets	150.64	144.81	135.95	82.96	61.38	42.30
Less : Current Liabilities and Provisions	0.00	0.00	0.00	0.00	0.00	0.00
Current Liabilities	55.83	51.39	86.10	75.68	18.92	14.10
Provisions	14.08	8.13	5.96	1.76	1.67	6.20
Total Current Liabilities	69.91	59.52	92.06	77.44	20.59	20.30
Net Current Assets	80.73	85.29	43.89	5.52	40.79	22.00
Miscellaneous Expenses not written off	0.00	0.00	0.00	0.00	0.00	0.00
Deferred Tax Assets	12.43	6.79	5.65	2.03	5.14	12.51
Deferred Tax Liability	1.14	0.90	4.41	6.19	0.00	7.28
Net Deferred Tax	11.29	5.89	1.24	-4.16	5.14	5.23
Other Assets	29.91	22.33	17.29	21.67	17.13	12.62
Total Assets
Contingent Liabilities	1.61	1.61	50.83	54.33	40.80	50.35

Cash Flow

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

PARTICULARS	Mar 2023	Mar 2022	Mar 2021	Mar 2020	Mar 2019
Cash and Cash Equivalents at Beginning of the year	11.50	5.05	4.88	4.36	7.24
Net Cash from Operating Activities	120.02	105.68	111.07	136.33	96.56
Net Cash Used In Investing Activities	-31.65	-12.32	-53.09	26.84	-3.30
Net Cash Used In Financing Activities	-87.50	-86.91	-57.81	-162.65	-96.14
Net Inc./Dec In Cash And Cash Equivalents	0.87	6.45	0.17	0.52	-2.88
Cash And Cash Equivalents At End Of The Year	12.37	11.50	5.05	4.88	4.36

Share Holding

These are actions taken by a company that impact the shareholders value directly. It is an event that brings material changes to a company and affects its stakeholders.

Promoter Shareholding

71.11%

FII Shareholding

2.90%

DII Shareholding

14.88%

Public Shareholding

11.10%

**Promoter pledged shareholding 71.11%

About Thyrocare Technologies Ltd

Thyrocare Technologies Ltd is in the Healthcare sector, having a market capitalization of Rs. 3396.91 crores. It has reported a sales of Rs. 122.89 crores and a net profit of Rs. 14.89 crores for the quarter ended December 2018. The company management includes Rahul Guha, GOPAL SHIVRAM HEGDE,Neetin Shivajirao Desai,VISHWAS MADHAV KULKARNI,RAMJEE DORAI,Indumati Gopinathan,Dhaval Shah,Dharmil Sheth,Rahul Guha,Hardik Dedhia,Prapti Ishwar Gilada,Harshil Jiten Vora (Thyrocare Technologies Ltd) among others.

Chairman

Rahul Guha

Registered office

D-37/1 TTC Industrial Area,MIDC Turbhe,Navi Mumbai,Maharashtra,400703

FAX :91-22-27682409

Background

Incorporation Year2000

Face Value₹10

Market Lot1

How to buy Thyrocare Tech. shares on nse?

To buy Thyrocare Tech. shares in Motilal Oswal, you just need to open a demat account and get your KYC documents verified

What is the Thyrocare Tech. share price today?

The Thyrocare Tech. shares price on nse is Rs.629.55 today.

What is the market cap of Thyrocare Tech. shares on NSE ?

The company has a market capitalization of Rs.3410.95Cr

What is the PE & PB ratio of Thyrocare Tech. shares ?

PE is 54.92 and PB is 7.19

What is the 52 Week High and Low of Thyrocare Tech. shares?

Thyrocare Tech. stock price high: Rs.722.65 Thyrocare Tech. stock price low: Rs.446.8